See more : SpareBank 1 Sørøst-Norge (SOON.OL) Income Statement Analysis – Financial Results
Complete financial analysis of Raia Drogasil S.A. (RADLY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Raia Drogasil S.A., a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- Synergie Wellness Products, Inc. (SYHO) Income Statement Analysis – Financial Results
- Belysse Group NV (BELYS.BR) Income Statement Analysis – Financial Results
- Cohort plc (CHRT.L) Income Statement Analysis – Financial Results
- Sparta Commercial Services, Inc. (SRCO) Income Statement Analysis – Financial Results
- Bhagyanagar India Limited (BHAGYNAGAR.BO) Income Statement Analysis – Financial Results
Raia Drogasil S.A. (RADLY)
About Raia Drogasil S.A.
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. As of March 31, 2022, the company operated a network of 2,530 drug stores in 26 Brazilian states. It also markets its goods through telesales and its three call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 33.97B | 29.07B | 24.13B | 20.07B | 17.57B | 14.80B | 13.21B | 11.26B | 8.90B | 7.39B | 6.23B | 5.38B | 2.73B | 2.01B | 1.72B | 1.26B | 833.07M | 674.43M | 539.17M | 426.92M | 344.67M |
| Cost of Revenue | 23.77B | 20.26B | 16.92B | 14.18B | 12.37B | 10.36B | 9.22B | 7.75B | 6.18B | 5.28B | 4.51B | 3.89B | 2.01B | 1.53B | 1.32B | 965.99M | 606.24M | 489.91M | 390.00M | 305.94M | 237.06M |
| Gross Profit | 10.21B | 8.81B | 7.21B | 5.89B | 5.20B | 4.45B | 3.99B | 3.50B | 2.71B | 2.11B | 1.72B | 1.49B | 717.92M | 478.40M | 398.85M | 294.16M | 226.83M | 184.52M | 149.17M | 120.98M | 107.61M |
| Gross Profit Ratio | 30.04% | 30.31% | 29.87% | 29.36% | 29.59% | 30.03% | 30.18% | 31.13% | 30.51% | 28.55% | 27.60% | 27.74% | 26.30% | 23.86% | 23.18% | 23.34% | 27.23% | 27.36% | 27.67% | 28.34% | 31.22% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.50B | 1.25B | 912.33M | 699.76M | 548.71M | 416.48M | 328.66M | 297.73M | 235.09M | 194.96M | 176.46M | 171.45M | 87.67M | 51.69M | 56.23M | 40.37M | 26.97M | 3.22M | 22.19M | 17.64M | 16.69M |
| Selling & Marketing | 6.69B | 5.81B | 4.97B | 4.26B | 3.75B | 3.26B | 2.53B | 2.22B | 1.74B | 1.41B | 1.19B | 1.00B | 464.11M | 317.66M | 251.09M | 194.11M | 148.04M | 120.94M | 106.85M | 83.37M | 71.14M |
| SG&A | 8.19B | 7.06B | 5.88B | 4.96B | 4.30B | 3.68B | 2.86B | 2.52B | 1.98B | 1.60B | 1.36B | 1.17B | 464.11M | 369.36M | 56.23M | 234.48M | 175.01M | 124.16M | 129.04M | 101.00M | 87.84M |
| Other Expenses | -65.93M | 106.64M | 75.16M | -10.33M | -798.00K | -716.00K | -13.52M | -5.07M | -810.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -174.00K | -163.00K | 52.65M | 667.00K | 2.05M | 485.00K |
| Operating Expenses | 8.13B | 6.98B | 5.83B | 4.96B | 4.30B | 3.68B | 3.20B | 2.80B | 2.21B | 1.80B | 1.57B | 1.33B | 638.36M | 366.17M | 302.05M | 263.08M | 203.49M | 211.39M | 136.53M | 112.40M | 98.51M |
| Cost & Expenses | 31.89B | 27.23B | 22.75B | 19.14B | 16.67B | 14.03B | 12.42B | 10.55B | 8.40B | 7.08B | 6.08B | 5.22B | 2.65B | 1.89B | 1.62B | 1.23B | 809.72M | 701.30M | 526.53M | 418.35M | 335.58M |
| Interest Income | 45.91M | 487.00K | 64.00K | 6.14M | 7.07M | 11.14M | 0.00 | 0.00 | 0.00 | 8.00K | 154.00K | 92.00K | 22.45M | 14.12M | 13.27M | 30.92M | 15.96M | 5.94M | 0.00 | 0.00 | 0.00 |
| Interest Expense | 737.79M | 292.69M | 228.23M | 234.09M | 224.50M | 1.25M | 43.78M | 37.84M | 7.09M | 935.00K | 2.18M | 1.81M | 10.80M | 5.52M | 4.86M | 4.43M | 8.14M | 3.67M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 797.69M | 1.47B | 1.29B | 1.15B | 1.11B | 414.13M | 337.91M | 274.43M | 227.70M | 187.57M | 158.74M | 124.33M | 55.67M | 31.29M | 21.77M | 18.38M | 11.22M | 9.11M | 10.77M | 15.02M | 13.79M |
| EBITDA | 2.75B | 2.45B | 2.63B | 2.03B | 1.83B | 1.09B | 1.11B | 965.93M | 716.72M | 539.81M | 371.32M | 284.21M | 157.68M | 157.64M | 131.85M | 49.45M | 50.36M | 43.09M | 23.41M | 23.59M | 22.89M |
| EBITDA Ratio | 8.10% | 10.31% | 10.57% | 10.12% | 10.40% | 7.43% | 7.78% | 7.86% | 7.49% | 6.64% | 4.82% | 5.28% | 5.78% | 7.86% | 7.66% | 3.92% | 6.05% | 8.57% | 4.34% | 5.53% | 6.64% |
| Operating Income | 2.08B | 1.48B | 1.22B | 854.20M | 785.08M | 721.51M | 792.58M | 705.54M | 88.79M | 309.13M | 149.83M | 160.62M | 79.56M | 112.23M | 96.81M | 47.88M | 23.35M | -26.88M | 12.64M | 8.57M | 9.10M |
| Operating Income Ratio | 6.12% | 5.09% | 5.07% | 4.26% | 4.47% | 4.87% | 6.00% | 6.27% | 1.00% | 4.18% | 2.40% | 2.99% | 2.91% | 5.60% | 5.63% | 3.80% | 2.80% | -3.98% | 2.34% | 2.01% | 2.64% |
| Total Other Income/Expenses | -863.80M | -646.12M | -339.68M | -237.83M | -111.68M | -142.20M | -106.04M | -110.32M | -64.96M | -6.90M | -10.45M | -2.55M | 11.65M | 8.60M | 8.42M | 21.89M | 7.82M | -1.10M | 667.00K | 2.05M | 485.00K |
| Income Before Tax | 1.22B | 1.19B | 987.26M | 616.37M | 784.17M | 638.86M | 686.54M | 595.22M | 435.90M | 302.22M | 139.39M | 158.07M | 91.21M | 120.83M | 105.22M | 69.77M | 31.00M | 28.05M | 13.30M | 10.62M | 9.58M |
| Income Before Tax Ratio | 3.58% | 4.10% | 4.09% | 3.07% | 4.46% | 4.32% | 5.20% | 5.29% | 4.90% | 4.09% | 2.24% | 2.94% | 3.34% | 6.03% | 6.12% | 5.54% | 3.72% | 4.16% | 2.47% | 2.49% | 2.78% |
| Income Tax Expense | 129.55M | 178.24M | 223.13M | 120.84M | -4.57M | 129.54M | 173.89M | 143.96M | 96.12M | 80.84M | 38.40M | 53.22M | 22.51M | 31.81M | 30.63M | 18.60M | 9.38M | 82.85M | 3.44M | 2.71M | 2.47M |
| Net Income | 1.05B | 996.11M | 751.93M | 484.44M | 772.24M | 502.45M | 511.16M | 447.69M | 340.21M | 221.39M | 100.99M | 104.86M | 68.70M | 89.02M | 74.59M | 51.17M | 21.63M | 20.80M | 9.73M | 7.95M | 6.96M |
| Net Income Ratio | 3.11% | 3.43% | 3.12% | 2.41% | 4.40% | 3.39% | 3.87% | 3.98% | 3.82% | 3.00% | 1.62% | 1.95% | 2.52% | 4.44% | 4.34% | 4.06% | 2.60% | 3.08% | 1.80% | 1.86% | 2.02% |
| EPS | 0.62 | 0.58 | 0.44 | 0.28 | 0.45 | 0.29 | 0.30 | 0.26 | 0.20 | 0.13 | 0.06 | 0.06 | 0.07 | 0.10 | 0.08 | 0.06 | 0.02 | 0.03 | 0.01 | 0.01 | 0.01 |
| EPS Diluted | 0.62 | 0.58 | 0.44 | 0.28 | 0.45 | 0.29 | 0.30 | 0.26 | 0.20 | 0.13 | 0.06 | 0.06 | 0.07 | 0.09 | 0.08 | 0.06 | 0.02 | 0.03 | 0.01 | 0.01 | 0.01 |
| Weighted Avg Shares Out | 1.70B | 1.71B | 1.72B | 1.72B | 1.71B | 1.71B | 1.71B | 1.71B | 1.71B | 1.71B | 1.72B | 1.72B | 917.15M | 934.48M | 923.37M | 921.34M | 992.25M | 734.77M | 734.45M | 734.45M | 734.45M |
| Weighted Avg Shares Out (Dil) | 1.70B | 1.72B | 1.72B | 1.72B | 1.72B | 1.71B | 1.72B | 1.71B | 1.71B | 1.71B | 1.72B | 1.72B | 917.15M | 938.55M | 928.77M | 921.34M | 992.25M | 734.77M | 734.45M | 734.45M | 734.45M |
What's Hot, What's Not: China Stocks Are Out. Top Picks From 3 Other Countries
A day doesn't go by when another large asset management firm discusses why they are abandoning China for other international stock picks. The reality is that China stocks are out, but you should still consider stocks from other foreign countries.
3 Stocks to Ride the Latin America Market Boom in 2024
Hugo Ste-Marie and the rest of his portfolio strategists at the Bank of Nova Scotia recently compiled a list of 10 major market themes for 2024. One of them was about Latin America stocks.
The 3 Best South American Stocks to Buy in 2023
2022 was a tough year for most global equities markets. One notable exception was Latin America.
Source: https://incomestatements.info
Category: Stock Reports